olpasiran   Click here for help

GtoPdb Ligand ID: 13709

Synonyms: AMG-890 | AMG890
Compound class: Nucleic acid
Comment: Olpasiran (AMG890) is an apolipoprotein A synthesis reducer. It is a GalNac-conjugated short interfering RNA (siRNA) that was designed to treat atherosclerotic cardiovascular disease in patients with elevated lipoprotein A [1-2].
We have been unable to locate a full chemical SMILES for the drug, or its HELM notation. We provide the basic nucleic acid structure for the molecule here. Full specifications for all modifications are available from its INN record.
Classification Click here for help
Compound class Nucleic acid
Compound subclass siRNA
Target apolipoprotein A
International Nonproprietary Names Click here for help
INN number INN
11099 olpasiran
Synonyms Click here for help
AMG-890 | AMG890
Database Links Click here for help
CAS Registry No. 2808361-18-2 (source: WHO INN record)
GtoPdb PubChem SID 507750343
Search PubMed clinical trials olpasiran
Search PubMed titles olpasiran
Search PubMed titles/abstracts olpasiran